ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0003250 | Antibodies produced by a single clone of cells. | MAb|Monoclonal antibodies|Monoclonal Antibody|Monoclonal protein|Monoclonal Antibody Therapy|Product containing monoclonal antibody (product)|Monoclonal Antibodies|Antibodies, Monoclonal|monoclonal antibody|Monoclonal immunoglobulin-containing product|monoclonal antibodies|Monoclonal immunoglobulin|Monoclonal antibody (substance)|Monoclonal antibody|MoAB|Monoclonal antibody-containing product | Monoclonal Antibodies |
C0208355 | A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. | 20S Core Proteasome|Multicatalytic endopeptidase complex|Endopeptidase Complex, Multicatalytic|Multicatalytic Endopeptidase Complex|Complex, Multicatalytic Endopeptidase|Proteasome, 20S|20S Proteasome|Proteasome Endopeptidase Complex|Multicatalytic endopeptidase complex (substance)|Prosome|Endopeptidase Complex, Proteasome|Proteasome|proteasome|Multicatalytic proteinase (complex)|20S Catalytic Proteasome|Macropain|Multicatalytic Proteinase|prosome|Proteosome|20S Proteosome|Macroxyproteinase|Proteinase, Multicatalytic|Complex, Proteasome Endopeptidase|proteasomes | multicatalytic endopeptidase complex |
C1527009 | Non-terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters. [GOC:nln] | varicosity | axon varicosity |
C0017279 | Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. | gag Gene Product|group specific antigen|Antigens, gag|Gene Product, gag|Polyprotein, gag|gag Viral Proteins|gag Polyprotein|gag Proteins, Viral|Viral gag Proteins|Group-Specific Antigen Protein|gag Polyproteins|gag Gene Products|Retroviral Antigen gag Protein|gag protein|Viral Proteins, gag|gag Antigens|gag Protein|Protein, gag|GAG Protein|Polyproteins, gag|Proteins, Viral gag|Proteins, gag Viral | Gene Products, gag |
C1059647 | null | Tomato yellow leaf curl Sardinia virus|Tomato yellow leaf curl virus- Sardinia|Tomato yellow leaf curl virus-Sardinia|tomato yellow leaf curl virus-Sar|Tomato yellow leaf curl virus - Sardinia | Tomato yellow leaf curl Sardinia virus |
C0242961 | A unique DNA sequence of a replicon at which DNA REPLICATION is initiated and proceeds bidirectionally or unidirectionally. It contains the sites where the first separation of the complementary strands occurs, a primer RNA is synthesized, and the switch from primer RNA to DNA synthesis takes place. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) | Regions, ori|ORI|Region, ori|Origins, Replication|Origin, Replication|ori Region|ori Regions|Autonomously Replicating Sequence|Replication Origins|Origin of Replication|ARS|Replication Origin | Replication Origin |
C0887859 | null | Intercistronic Regions|Intercistronic Region|Region, Intergenic|Regions, Intergenic|Regions, Intercistronic|Region, Intercistronic|Intergenic Regions | Intergenic Region |
C1073656 | null | rhesus macaque rhadinovirus|Macacine herpesvirus 5|Cercopithecine herpesvirus 17 | Macacine gammaherpesvirus 5 |
C0443299 | Independent; not united or joint. | Separate (qualifier value)|Separate|separating|separated|separate|Discrete | Separate |
C0007874 | The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal. | Cervix uteri including exocervix and endocervix|Genital Cervix|of uterus cervix|Cervixes|Cervix/Uterus|Uterus, Cervix|Neck of uterus|Uterine cervix|neck of uterus|UTERINE CERVIX|Cervical canal of uterus|Cervix uteri, NOS|cervix uterine|Cervix uteri|Cervix Uteri|cervixes|Canalis cervicis uteri|cervix uteri|Uterine Cervix|Genital System, Female, Cervix|uterine cervix|Cervix uteri structure|CERVIX|Cervix uteri (exocervix and endocervix)|Cervix, NOS|neck uterus|Cervix uteri structure (body structure)|cervix|CERVIX UTERI|Cervix, Uterine|Cervix of uterus|of cervix uterus|Cervix|Uterine cervix, NOS|Cervical canal | Cervix Uteri |
C1152887 | null | Rab escort protein activity | RAB escort protein activity |
C0007874 | The neck portion of the UTERUS between the lower isthmus and the VAGINA forming the cervical canal. | Cervix uteri including exocervix and endocervix|Genital Cervix|of uterus cervix|Cervixes|Cervix/Uterus|Uterus, Cervix|Neck of uterus|Uterine cervix|neck of uterus|UTERINE CERVIX|Cervical canal of uterus|Cervix uteri, NOS|cervix uterine|Cervix uteri|Cervix Uteri|cervixes|Canalis cervicis uteri|cervix uteri|Uterine Cervix|Genital System, Female, Cervix|uterine cervix|Cervix uteri structure|CERVIX|Cervix uteri (exocervix and endocervix)|Cervix, NOS|neck uterus|Cervix uteri structure (body structure)|cervix|CERVIX UTERI|Cervix, Uterine|Cervix of uterus|of cervix uterus|Cervix|Uterine cervix, NOS|Cervical canal | Cervix Uteri |
C0949908 | A genus in the family RHABDOVIRIDAE, infecting numerous species of fish with broad geographic distribution. The type species is INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS. | Novirhabdoviruses|Genus Novirhabdovirus (organism)|Genus Novirhabdovirus|Novirhabdovirus | Novirhabdovirus |
C0597363 | virus into which recombinant nucleic acid has been introduced, or whose genome has been modified in vitro by recombinant nucleic acid techniques; also index specific virus. | null | recombinant virus |
C0023476 | null | Ph1-Positive Myelocytic Leukemia|Philadelphia-Positive Myelocytic Leukemia|Philadelphia-Positive Myelogenous Leukemia|Ph1-Positive Granulocytic Leukemia|Philadelphia-Positive Myeloid Leukemia|Ph1-Positive Myeloid Leukemia|Philadelphia-Positive Granulocytic Leukemia|Ph1-Positive Myelogenous Leukemia | Philadelphia-Positive Myelogenous Leukemia |
C0030358 | A genus of viruses (family Papovaviridae) containing DNA, having virions about 55 nm in diameter, and including the papilloma and warts viruses of man and other animals, some of which are associated with inductions of carcinoma. | Papillomavirus species|Genus Papillomavirus|papillomaviruses|Papillomavirus group|papillomavirus|papilloma virus|Papilloma virus|Papilloma Viruses|PAPILLOMAVIRUS|Papillomavirus, NOS|papilloma viruses|Genus Papillomavirus (organism)|Papillomavirus|Papillomaviruses|Papilloma Virus|Virus-Papilloma|Papillomavirus group, NOS | Papillomavirus |
C0162493 | Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. | Transcription Activation|Up-Regulation|Activation, Transcription|Transcriptional Activation|Activation, Transcriptional | Transcriptional Activation |
C0029347 | A negative-strand linear single-strand RNA virus with an 8 segment genome. Virions are enveloped and usually spherical or pleomorphic, 80-120 nm in diameter. Subtyping is based on the antigenic properties of the hemagglutinin and neuraminidase proteins. Influenza type A viruses can infect people, birds, pigs, horses, and other animals, but wild birds are the natural hosts for these viruses. | Influenza A virus (organism)|INFLUENZA A VIRUS|Human Influenza A Virus|Influenza A viruses|Influenza virus type A|Influenza A virus|influenza A virus|Influenza Viruses Type A|Influenza A Virus|influenza a virus|Influenza Virus Type A|Orthomyxovirus Type A|Influenza virus A|FLUAV | influenza A virus |
C0060489 | null | FLUFYLLINE|flufyllin|7-(2-(4-(4-fluorobenzoyl)piperidino)ethyl)theophylline|Flufylline | flufylline |
C0010723 | An enzyme that catalyzes the deamination of cytidine, forming uridine. EC 3.5.4.5. | Cytidine Aminohydrolase|Cytidine deaminase|Cytidine aminohydrolase|EC 3.5.4.5|Deaminase, Cytidine|Cytidine Deaminase|Cytidine deaminase (substance)|Aminohydrolase, Cytidine | Cytidine Deaminase |
C0019904 | An individual in which both alleles at a given locus are identical. | Homozygotes|Homozygous|Homozygote (finding)|homozygous genotype|Homozygosity|homozygote|Homozygote | Homozygote |
C0521029 | null | null | Reoviral |
C0521029 | null | null | Reoviral |
C1435637 | null | Arl proteins|Arf-like proteins | ADP ribosylation factor like proteins |
C0025646 | A sulfur-containing essential L-amino acid that is important in many body functions. | Racemethionine-containing product|Methionine, L-Isomer|L-(-)-methionine|L-Methionine|L-α-amino-γ-methylmercaptobutyric acid|Methionine-containing product|l-methionine|L-Methionin|(S)-2-amino-4-(methylthio)butanoic acid|Met|L-Isomer Methionine|Methionine|(S)-2-amino-4-(methylthio)butyric acid|(2S)-2-amino-4-(methylsulfanyl)butanoic acid|Product containing methionine (medicinal product)|METHIONINE|L-a-Amino-g-methylthiobutyric acid|L-methionine (substance)|M|methionine|(S)-methionine|Methionine, L Isomer|L-methionine|(S)-2-Amino-4-(methyl-sulfanyl)butanoic acid|l methionine | methionine |
C1334999 | A non-neoplastic disorder that affects the heart and/or vessels. Representative examples include myocardial infarction, endocarditis, arteriosclerosis, thrombosis, and lymphedema. | Non-Neoplastic Cardiovascular Disease | Non-Neoplastic Cardiovascular Disorder |
C1334999 | A non-neoplastic disorder that affects the heart and/or vessels. Representative examples include myocardial infarction, endocarditis, arteriosclerosis, thrombosis, and lymphedema. | Non-Neoplastic Cardiovascular Disease | Non-Neoplastic Cardiovascular Disorder |
C1334998 | A non-neoplastic disorder that affects the breast. Representative examples include fibrocystic disease, gynecomastia, mastitis, and adenosis. | Non-Neoplastic Disease of the Breast|Non-Neoplastic Disease of Breast|Non-Neoplastic Breast Disease | Non-Neoplastic Breast Disorder |
C1334998 | A non-neoplastic disorder that affects the breast. Representative examples include fibrocystic disease, gynecomastia, mastitis, and adenosis. | Non-Neoplastic Disease of the Breast|Non-Neoplastic Disease of Breast|Non-Neoplastic Breast Disease | Non-Neoplastic Breast Disorder |
C1279254 | null | Entire thymic lobule (body structure)|Entire thymic lobule | Entire thymic lobule |
C0969669 | A family of structurally related collagens that form the characteristic collagen fibril bundles seen in CONNECTIVE TISSUE. | Fibrillar Collagens|Fibrillar Collagen|Fibrillar collagen|Fibril-forming collagen|Collagens, Fibrillar|Collagen, Fibrillar | Fibrillar Collagen |
C0229951 | A reticular epithelial cell generated in the thymus that affects T-lymphocyte cell production. Thymic epithelial cells are organized in a three-dimensional network rather than as a sheet of cells on a basement membrane. | Epithelial reticular cell of thymus|Epithlelial cell of thymus gland|Thymic Epithelial Cell|Thymic epithelial cell|Epithelial cell of thymus|Thymic epithelial cell (cell)|TEC|Epithelial reticular cell | Thymic epithelial cell |
C0949610 | Proteins encoded by the mitochondrial genome or proteins encoded by the nuclear genome that are imported to and resident in the MITOCHONDRIA. | Proteins, Mitochondrial|Protein, Mitochondrial|Mitochondrial Protein|mitochondrial protein|mitochondrial proteins | Mitochondrial Proteins |
C0051385 | null | .ALPHA.-IONONE|alpha ionone|alpha-ionone|4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one | alpha ionone |
C0051385 | null | .ALPHA.-IONONE|alpha ionone|alpha-ionone|4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one | alpha ionone |
C0037799 | A high molecular weight (220-250 kDa) water-soluble protein which can be extracted from erythrocyte ghosts in low ionic strength buffers. The protein contains no lipids or carbohydrates, is the predominant species of peripheral erythrocyte membrane proteins, and exists as a fibrous coating on the inner, cytoplasmic surface of the membrane. | Spectrin (substance)|Spectrins|Spectrin|spectrin | Spectrin |
C0379099 | Proton-translocating ATPases that are involved in acidification of a variety of intracellular compartments. | Lysosomal F(1)F(0) ATPase|Vacuolar Membrane H(+)-ATPase|Vacuolar F(1)F(0) ATPase|Lysosomal Proton Translocating ATPases|Vacuolar H+-ATPase|Vacuolar F(1)F(0) ATPases|Vacuolar H+ ATPase|Vacuolar Proton-Translocating ATPases|ATPase, Vacuolar|ATPase, V-Type|H+-ATPase, Vacuolar|vacuolar h+-atpase|atpases vacuolar|Lysosomal Proton-Translocating ATPases|V Type ATPase|Proton-Translocating ATPases, Lysosomal|V-Type ATPase|ATPases, Lysosomal Proton-Translocating|Vacuolar ATPase | vacuolar H+-ATPase |
C0058836 | A family of high molecular weight GTP phosphohydrolases that play a direct role in vesicle transport. They associate with microtubule bundles (MICROTUBULES) and are believed to produce mechanical force via a process linked to GTP hydrolysis. This enzyme was formerly listed as EC 3.6.1.50. | Dynamins|dynamin|Dephosphin|Dynamin|dephosphin | Dynamin GTPase |
C0096069 | A dual specificity phosphatase subtype that plays a role in intracellular signal transduction by inactivating MITOGEN-ACTIVATED PROTEIN KINASES. It has specificity for P38 MITOGEN-ACTIVATED PROTEIN KINASES and JNK MITOGEN-ACTIVATED PROTEIN KINASES. | MAP Phosphatase-1|3CH134 Phosphatase|Map Kinase Phosphatase 1|Mitogen Activated Protein Phosphatase 1|Phosphatase, MKP-1|MAPK Phosphatase|Mitogen-Activated Protein Phosphatase-1|Phosphatase, MAPK|Externally Regulated Phosphatase (ERP)|CL100 Phosphatase|MKP 1 Phosphatase|Dual Specificity Phosphatase 1|Dual specificity phosphatase 1|MKP-1 Phosphatase|Phosphatase-1, MAP|Phosphatase-1, Mitogen-Activated Protein|Phosphatase, CL100|MAP Phosphatase 1|Phosphatase, 3CH134|Protein Phosphatase-1, Mitogen-Activated | Dual Specificity Phosphatase 1 |
C0217250 | A ubiquitously expressed protein kinase that is involved in a variety of cellular SIGNAL PATHWAYS. Its activity is regulated by a variety of signaling protein tyrosine kinase. | Protein Kinase C delta|PKC-delta Serine-Threonine Kinase|PKC delta Serine Threonine Kinase|Kinase C-delta, Protein|Protein Kinase C-delta|Serine-Threonine Kinase, PKC-delta | Protein Kinase C-delta |
C0392164 | null | pulmonary cystic fibrosis|Cystic Fibrosis, Pulmonary|Cystic fibrosis of the lung|Pulmonary cystic fibrosis|cystic fibrosis lungs|CYSTIC FIBROSIS LUNG|Mucoviscidosis involving the lung|Cystic fibrosis of the lung (disorder)|cystic fibrosis lung | Pulmonary Cystic Fibrosis |
C0003705 | null | Poisoning caused by venomous spider (disorder)|ARANEISM|Poisoning caused by venomous spider|Poisoning due to venomous spider|Poisoning by venomous spider bite, NOS | Arachnidism |
C0751984 | A class of monomeric, low molecular weight (20-25 kDa) GTP-binding proteins that regulate a variety of intracellular processes. The GTP bound form of the protein is active and limited by its inherent GTPase activity, which is controlled by an array of GTPase activators, GDP dissociation inhibitors, and guanine nucleotide exchange factors. This enzyme was formerly listed as EC 3.6.1.47 | GTP-Binding Proteins, Monomeric|Monomeric G-Proteins|G Proteins, Monomeric|G-Proteins, Small|Small GTPases|Small G-Proteins|Monomeric GTP Binding Proteins|GTPases, Small|Monomeric G Proteins|G-Proteins, Monomeric|GTP Binding Proteins, Monomeric|Small G Protein|Small G Proteins | Monomeric GTP-Binding Proteins |
C0965282 | null | phospholipase Cepsilon | phospholipase C epsilon |
C0333833 | null | Ragocyte|RA cell|Ragocyte (morphologic abnormality) | Ragocyte |
C0008778 | Populations of thin, motile processes found covering the surface of ciliates (CILIOPHORA) or the free surface of the cells making up ciliated EPITHELIUM. Each cilium arises from a basic granule in the superficial layer of CYTOPLASM. The movement of cilia propels ciliates through the liquid in which they live. The movement of cilia on a ciliated epithelium serves to propel a surface layer of mucus or fluid. (King & Stansfield, A Dictionary of Genetics, 4th ed) | microtubule-based flagellum|cilia|cilium|Cilium, NOS|eukaryotic flagellum|Cilium (cell structure)|Cilium|Cilia | Cilia |
C0390154 | null | autosomal dominant polycystic kidney disease type II protein|polycystic kidney disease 2 protein|polycystin 2 | polycystic kidney disease 2 protein |
C0256073 | Polycystin-1 (4303 aa, ~463 kDa) is encoded by the human PKD1 gene. This protein may play a role in protein-protein and protein-carbohydrate interactions during kidney development. | PKD1 protein|Autosomal Dominant Polycystic Kidney Disease Protein 1|polycystin 1|Polycystin-1|polycystic breakpoint (PBP) protein|polycystic kidney disease 1 protein|pcy protein | polycystic kidney disease 1 protein |
C0010467 | A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. | diferuloylmethane|Yellow, Turmeric|tumeric|Diferuloylmethane|Curcumin|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-|curcumin|Curcumin stain|CURCUMIN|Turmeric Yellow|C.I. Natural Yellow 3|Tumeric|(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione|Curcumin stain (substance)|CU | curcumin |
C0010467 | A yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes. | diferuloylmethane|Yellow, Turmeric|tumeric|Diferuloylmethane|Curcumin|1,6-Heptadiene-3,5-dione, 1,7-bis(4-hydroxy-3-methoxyphenyl)-, (E,E)-|curcumin|Curcumin stain|CURCUMIN|Turmeric Yellow|C.I. Natural Yellow 3|Tumeric|(E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione|Curcumin stain (substance)|CU | curcumin |
C0012203 | A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) | 3, 4-Bis(p-hydroxyphenyl)-3-hexene|Diethylstilbestrolum|3-Hexene,3,4-bis(p-hydroxyphenyl)-|3,4-Bis(p-hydroxyphenyl)-3-hexene|Diethylstilbestrol preparation|DES preparation|4,4'-dihydroxy-alpha,beta-diethylstilbene|Stilbestrol|4,4'-dihydroxy-α,β-diethylstilbene|Diethylstilbenediol|trans-Diethylstilbesterol|Diethylstilboestrol|(E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|4,4'-Dihydroxy-.alpha., .beta.-diethylstilbene|Diethylstilbestrol (substance)|Diethylstilbestrol-containing product|Trans-bis-(hydroxy-4-phenyl)-3,4 hexene-3|trans-bis-(hydroxy-4-phenyl)-3,4 hexene-3|stilbestrol|Diethylstilbestrol|Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, (E)-|diethylstilbestrol (DES)|DES|Palestrol|trans-Diethylstilboesterol|α,α'-diethyl-(E)-4,4'-stilbenediol|Dietilestilbestrol|3,4-bis(p-hydroxyphenyl)-3-hexene|alpha,alpha'-diethylstilbenediol|Estrogen, Stilbene|trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol|(E)-3,4-bis(4-hydroxyphenyl)-3-hexene|Product containing diethylstilbestrol (medicinal product)|trans-Diethylstilbestrol|Alpha,alpha'-diethylstilbenediol|Stilboestrol|diethylstilbestrol|diethylstilbestrolum|Stilbene Estrogen|DIETHYLSTILBESTROL|Diéthylstilbestrol|4,4'-Dihydroxy-alpha,beta-diethylstilbene|Stilbestrol preparation|.alpha., .alpha.'-Diethylstilbenediol | diethylstilbestrol |
C0016384 | An antiandrogen with about the same potency as cyproterone in rodent and canine species. | Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-|flutamide|Niftolid|Product containing flutamide (medicinal product)|Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-|Flutamid|Niftolide|2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide|Flutamidum|α,α,α-trifluoro-2-methyl-4'-nitro-m-propionotoluidide|FLUTAMIDE|Flutamide-containing product|NFBA|alpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide|4'-nitro-3'-trifluoromethylisobutyranilide|Flutamide (substance)|Alpha,alpha,alpha-trifluoro-2-methy-4'-nitro-m-propionotoluidide|FLUT|FTA|4'-Nitro-3'-trifluoromethylisobutyranilide|Flutamida|Flutamide|2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide | flutamide |
C0537565 | null | p-(1,1,3,3-tetramethylbutyl)-phenol|p-tert-octylphenol|4-tertiary-octylphenol | 4-tert-octylphenol |
C1141639 | A sialoglycoprotein hormone secreted by the placenta and maintains the corpus luteum at the beginning of the gestation period. | human chorionic gonadotropin (HCG)|Product containing human chorionic gonadotropin (medicinal product)|Chorionic gonadotrophin human|chorionic gonadotropin|Chorionic Gonadotropin|Human chorionic gonadotropin (HCG)|Human chorionic gonadotropin|human chorionic gonadotropin|Gonadotropin, Human Chorionic|h-HCG|Urinary hCG|Human-chorionic gonadotropin|Human chorionic gonadotropin-containing product|Human chorionic gonadotropin, NOS|HCG - Human chorionic gonadotrophin|Gonadotrophin, Chorionic|Human chorionic gonadotropin (substance)|hCG preparation|Gonadotropin, Chorionic|HCG preparation|HCG|Human Chorionic Gonadotropin|CHORIONIC GONADOTROPIN|human chorionic gonadotropins|Human chorionic gonadotrophin, NOS|HCG (Human Chorionic Gonadotropin)|hCG|Human menopausal gonadotropin (urine derived)|Human chorionic gonadotrophin|Chorionic Gonadotropin, Human|HCG - Human chorionic gonadotropin|Gonadotropin,chorionic|Gonadotropins, Chorionic, Human|Chorionic gonadotrophin|Chorionic gonadotropin human|Chorionic Gonadotropin (Human)|Chorionic gonadotropin|HUMAN CHORIONIC GONADOTROPIN|human chorionic gonadotrophin|GONADOTROPHIN, CHORIONIC | human chorionic gonadotropin |
C0032447 | Industrial products consisting of a mixture of chlorinated biphenyl congeners and isomers. These compounds are highly lipophilic and tend to accumulate in fat stores of animals. Many of these compounds are considered toxic and potential environmental pollutants. | polychlorinated biphenyl|Polychlorobiphenyl Compounds|PCBs|Biphenyls, Polychlorinated|polychlorinated biphenyls|Chlorinated Biphenyls|Polychlorinated biphenyl|pcb|polychlorinated biphenyl (PCB)|Chlorinated Biphenylsl|PCB|Polychlorinated Biphenyl|Polychlorinated biphenyl (substance)|polychlorobiphenyl|Polychlorinated biphenyls|Chlorobiphenyls|Polychlorinated Biphenyls|Compounds, Polychlorobiphenyl | Polychlorinated Biphenyls |
C1373178 | sum of chemical changes that occur within the liver of an organism consisting of anabolism (biosynthesis) and catabolism; the buildup and breakdown of molecules for utilization by the liver. | liver metabolism|metabolism liver|Hepatic Metabolism [PK] | Hepatic Metabolism |
C0017757 | Glucose-6-phosphate 1-dehydrogenase (515 aa, ~59 kDa) is encoded by the human G6PD gene. This protein plays a role in pentose metabolism to produce NADPH. | EC 1.1.1.49|glucose 6 phosphate dehydrogenase|Glucosephosphate Dehydrogenase|D-Glucose-6-phosphate:NADP+ 1-oxidoreductase|G6PD - Glucose-6-phosphate dehydrogenase|g6pd|Glucose 6 Phosphate Dehydrogenase|Glucosephosphate dehydrogenase|Glucose-6-phosphate dehydrogenase (G-6PD)|GLUCOSE 6 PHOSPHATE DEHYDROGENASE|Dehydrogenase, Glucose-6-Phosphate|Dehydrogenase, Glucosephosphate|G6PD|Glucose-6-Phosphate Dehydrogenase|Glucose-6-Phosphate 1-Dehydrogenase|G-6PD|glucose-6-phosphate dehydrogenase (G6PD)|G6P - Glucose-6-phosphate dehydrogenase|glucosephosphate dehydrogenase|g-6pd|Glucose-6-phosphate dehydrogenase (substance)|Glucose-6-phosphate dehydrogenase | Glucosephosphate Dehydrogenase |
C0031644 | An enzyme with high affinity for carbon dioxide. It catalyzes irreversibly the formation of oxaloacetate from phosphoenolpyruvate and carbon dioxide. This fixation of carbon dioxide in several bacteria and some plants is the first step in the biosynthesis of glucose. EC 4.1.1.31. | Phosphoenolpyruvate carboxylase (substance)|PEPCK (phosphoenolpyruvate carboxykinase)|pepck|PEPCK|Carboxylase, Phosphoenolpyruvate|Orthophosphate:oxaloacetate carboxy-lyase (phosphorylating)|Phosphoenolpyruvate carboxylase|phosphoenolpyruvate carboxykinase|Phosphoenolpyruvate Carboxylase|phosphoenolpyruvate carboxylase | Phosphoenolpyruvate Carboxylase |
C0001899 | An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. | alanine aminotransferase|alanine transaminase (ALT)|Glutamate pyruvate transaminase|Transaminase, Glutamic-Alanine|Alanine 2 Oxoglutarate Aminotransferase|glutamate pyruvate transaminase|ALT - alanine aminotransferase|Alanine aminotransferase (substance)|alanine transaminase|Alanine Transaminase|Alanine aminotransferase|alt alanine aminotransferase|Glutamic Alanine Transaminase|transaminase glutamic-pyruvic|alt|Aminotransferase, Alanine-2-Oxoglutarate|Glutamic-Alanine Transaminase|Glutamic-Pyruvic Transaminase|alts|gpt|Alanine-2-Oxoglutarate Aminotransferase|L-alanine:2-oxoglutarate aminotransferase|gpts|Transaminase, Glutamic-Pyruvic|L-Alanine:2-oxoglutarate aminotransferase|s-alat|ALT|Glutamic-alanine transaminase|glutamic pyruvic transaminase|Alanine Aminotransferase|glutamic-pyruvic transaminase|ALAT - alanine aminotransferase|L-alanine transaminase|Alanine transaminase|S-ALAT|glutamic alanine transaminase|Aminotransferase, Alanine|GPT|Glutamic Pyruvic Transaminase|Transaminase, Alanine|Glutamic-pyruvic transaminase | Alanine Transaminase |
C0086153 | Any alteration or treatment in an individual's diet with a planned goal, usually designed to improve the individual's overall health. | Diet Modification|intervention, dietary|Diet Modifications|Modification, Dietary|dietary modifications|dietary modification|Modification, Diet|diet modification|Dietary Intervention|Dietary Modifications|dietary interventions|Nutrition Interventions|Modifications, Dietary|Modifications, Diet|Dietary Modification|Nutritional Interventions|dietary intervention|diet modifications|Nutrition Intervention | Dietary Modification |
C0297331 | One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS. | Acid phosphatase bone isoenzyme|TRAcP|Tartrate-Resistant Acid Phosphatase|Phosphatase, Tartrate-Resistant Acid|Acid Phosphatase, Tartrate-Resistant|TRAP - Tartrate-resistant acid phosphatase|Tartrate-resistant acid phosphatase|Acid phosphatase bone isoenzyme (substance)|Tartrate Resistant Acid Phosphatase | tartrate-resistant acid phosphatase |
C0153690 | Cancer that has spread from the original (primary) tumor to the bone. | Tumor metastatic to bone|Metastatic malignant neoplasm to bone, NOS|Cancer metastatic to bone|Bony metastasis|bone metastasis|Bone Metastasis|osseous metastasis|Metastatic malignant neoplasm to bone|Bone Metastases|Metastatic Cancer to the Bone|Tumour metastatic to bone|secondary bone cancer|Metastases to bone, NOS|Metastatic Neoplasm to the Bone|metastases to bone|metastatic bone cancer|Metastatic tumor of bone|Secondary malignancy of bone|Secondary malignant neoplasm of bone, NOS|Secondary malignant neoplasm of bone (disorder)|Secondary cancer of bone|metastatic bone tumour|metastatic cancer to bone|Secondary malignant neoplasm of bone and bone marrow|bone, metastatic cancer to|cancer metastatic to bone|bony metastasis|metastatic bone tumor|Metastatic Tumor to the Bone|Metastatic Malignant Neoplasm to the Bone|Osseous metastasis|bone metastases|Metastatic Malignant Neoplasm in the Bone|BONE NEOPLASM SECONDARY|bony metastases|metastasis to bone|cancer, metastatic to bone|Metastatic tumour of bone | Secondary malignant neoplasm of bone |
C1149888 | Catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum. [EC:3.1.3.1] | phosphate-monoester phosphohydrolase (alkaline optimum)|alkaline phosphomonoesterase activity|alkaline phenyl phosphatase activity|alkaline phosphatase activity|alkaline phosphohydrolase activity|orthophosphoric-monoester phosphohydrolase (alkaline optimum) | alkaline phosphatase activity |
C0006644 | A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. | Mateína|theine|3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione|Cafeína|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|Trimethylxanthine|7-methyltheophylline|Caffeinum|caffeine|Guaranine|1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-|methyltheobromine|Thein|CAFFEINE|3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione|caffeine products|Caféine|Koffein|Theine|Caffeine (substance)|Caffeine|CAF|Caffeine, NOS|Methyltheobromine|Product containing caffeine (medicinal product)|Teína|Coffeinum|1,3,7-trimethyl-2,6-dioxopurine|1-methyltheobromine|1,3,7-trimethylxanthine|1,3,7-Trimethylxanthine|1,3,7-trimethylpurine-2,6-dione|Caffeine-containing product|Coffein | caffeine |
C0043210 | Human females as cultural, psychological, sociological, political, and economic entities. | female humans|Girl|Human Females|Girls|Woman|women|human female|female|woman|Women|female human|WOMAN|adult female?|Woman (person) | Woman |
C1273937 | null | Not significant (qualifier value) | Not significant |
C0919453 | Mutated forms of genes which encode proteins that are essential for the control and maintenance of normal cellular processes. Inherited or somatic mutations in the wild-type form of these genes alters control of their expression, resulting in a change in control of the cell cycle. Individuals who harbor cancer-predisposing genes require fewer somatic mutations for transformation of a particular cell, thereby predisposing them to the development of cancer. | susceptibility gene|Susceptibility Gene|cancer gene susceptibility|predisposing mutation|cancer-predisposing genes|Cancer Susceptibility Gene | Cancer-Predisposing Gene |
C0263541 | null | founders|Equine laminitis|Founder|equine laminitis|foundering|Equine laminitis (disorder)|founder | Equine laminitis |
C0017258 | null | Clusters, Gene|Cluster, Gene|Gene cluster|Gene Cluster | Gene Clusters |
C1265823 | null | Relapsing inflammation|Recurrent inflammation (morphologic abnormality) | Recurrent inflammation |
C0670896 | A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS. | Receptor, Toll-Like|Receptors, Toll-Like|Receptors, Toll Like|like receptors toll|toll-like receptors|Toll Like Receptor|Toll-Like Receptor|toll-like receptor|Toll-Like Receptors|toll like receptor|TLR protein|Toll Like Receptors | Toll-like receptors |
C0003693 | An enzyme that catalyzes the oxidation of arachidonic acid to yield 5-hydroperoxyarachidonate (5-HPETE) which is rapidly converted by a peroxidase to 5-hydroxy-6,8,11,14-eicosatetraenoate (5-HETE). The 5-hydroperoxides are preferentially formed in leukocytes. | Leukotriene A4 Synthetase|Arachidonate 5-lipoxygenase|Arachidonate 5-lipoxygenase (substance)|5-Lipoxygenase, Arachidonate|Arachidonate 5-Lipoxygenase|Arachidonic Acid 5-Lipoxygenase|Arachidonic Acid 5 Lipoxygenase|leukotriene synthase|Synthase, Leukotriene A4|LTA4 Synthase|5-Lipoxygenase, Arachidonic Acid|Arachidonate:oxygen 5-oxidoreductase|ALOX5|EC 1.13.11.34|Leukotriene A4 Synthase|Synthase, Leukotriene A|5 Lipoxygenase|5-LO|5-lipoxygenase|5-Lipoxygenase|Arachidonate 5 Lipoxygenase|Synthetase, Leukotriene A4|5 lipoxygenase|Synthase, LTA4|Leukotriene A Synthase | Arachidonate 5-Lipoxygenase |
C0072259 | Prostacyclin synthase (500 aa, ~57 kDa) is encoded by the human PTGIS gene. This protein plays a role in the mediation of prostaglandin biosynthesis. | Cytochrome p450 CYP8A1 enzyme (substance)|PGI2 synthetase|Prostacyclin synthase (substance)|prostacyclin synthetase|Cytochrome p450 CYP8A1 enzyme|Prostacyclin Synthase|CYP8A1|Prostaglandin I2 Synthase|PGI2 synthase|Prostacyclin synthase|prostacyclin isomerase|prostaglandin-I synthase|PGI isomerase|prostacyclin synthase|EC 5.3.99.4 | Prostacyclin synthase |
C0033554 | A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. | prostaglandin|prostanoid|PG|Prostaglandin (substance)|prostanoids|PG - Prostaglandin|PROSTAGLANDINS|Prostaglandin, NOS|prostaglandins|Product containing prostaglandin (product)|Prostanoids|Prostaglandins|Prostaglandin|Prostaglandin-containing product|Prostanoid|Prostanoid (substance) | Prostaglandins |
C0151779 | A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma. | Skin cancer (melanoma)|Malignant melanoma of skin (disorder)|CMM|SKIN CANCER, MELANOMA|cancer melanoma skin|malignant melanoma skin|skin cancer melanoma|cutaneous malignant melanoma|malignant cutaneous melanoma|Cutaneous melanoma|MELANOMA, CUTANEOUS MALIGNANT|Malignant melanoma of skin|MELANOMA, MALIGNANT|Melanoma of skin, site unspecified|Malignant Melanoma (of Skin), Stage Unspecified|Cutaneous Melanoma|melanoma skin|skin melanoma cancer|MM - Malignant melanoma of skin|MELANOMA SKIN|Melanoma, Cutaneous Malignant|Cutaneous malignant melanoma|Dysplastic Nevus Syndrome, Hereditary|Melanoma of Skin|Melanoma of skin (disorder)|melanoma skin cancer|Melanoma, Familial|Melanoma of the Skin|malignant melanoma of skin|melanoma, cutaneous|skin malignant melanoma|Familial Atypical Mole-Malignant Melanoma Syndrome|Skin cancer, melanoma|Skin Melanoma|Skin, Melanoma|Malignant Cutaneous Melanoma|Cutaneous (Skin) Melanoma|Malignant Melanoma of Skin|cutaneous melanoma|skin melanomas|skin melanoma|SKIN MELANOMA|Malignant melanoma of skin, NOS|melanomas of skin|Melanoma of skin|Skin cancers - melanoma|Malignant Melanoma of Skin Stage Unspecified|Melanomas of skin|Famm | Cutaneous Melanoma |
C0037278 | Skin diseases caused by bacteria, fungi, parasites, or viruses. | Diseases, Infectious Skin|Infection of skin and/or subcutaneous tissue|infectious skin diseases|Infectious Skin Disease|Infection of skin|Skin Diseases, Infectious|INFECTIONS OF THE SKIN AND SUBCUTANEOUS TISSUES|Skin--Infections|Skin infection|Infection of skin and subcutaneous tissue, NOS|Skin Disease, Infectious|infection of skin|infectious skin disease|skin infection|Skin and subcutaneous tissue infections|Disease, Infectious Skin|Skin infection NOS|Infective dermatological disorders|Infection of skin (disorder)|SKIN INFECTION|Infectious Skin Diseases|Skin Infections|Skin and subcutaneous tissue infection|Infection of skin and/or subcutaneous tissue (disorder)|INFECTIONS OF SKIN AND SUBCUTANEOUS TISSUE|Skin Infection|Skin infections | Skin Diseases, Infectious |
C0022602 | White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA. | Keratosis, Actinic|keratosis, actinic|senile keratosis|AK - Actinic keratosis|Actinic Keratosis|Actinic (Solar) Keratosis|Senile keratosis|Senile hyperkeratosis|Keratinocytic intraepidermal neoplasia|Keratosis, actinic|ACTINIC KERATOSIS|Actinic Keratoses|Keratoses, Actinic|Hyperplastic keratosis|Solar keratosis|SENILE SOLAR KERATOSIS|actinic keratosis|SK - Solar keratosis|Senile keratoma|Actinic keratosis (morphologic abnormality)|KERATOSIS, ACTINIC|Actinic keratosis (disorder)|Solar Keratosis|Actinic keratosis|Atrophic keratosis|solar keratosis|Actinic keratoses | Actinic keratosis |
C0001577 | Inflammation of the appendages of the uterus. | ADNEXITIS|Adnexitis|Uterine Adnexitis|adnexitis | Adnexitis |
C1331544 | A melanoma arising from the scrotum. | Melanoma of Scrotum|Scrotal Melanoma|Melanoma of the Scrotum | Scrotal Melanoma |
C1331544 | A melanoma arising from the scrotum. | Melanoma of Scrotum|Scrotal Melanoma|Melanoma of the Scrotum | Scrotal Melanoma |
C0911543 | null | null | CP172732 |
C0911543 | null | null | CP172732 |
C0008625 | Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. | Chromosome Aberration|Abnormality, Cytogenetic|Abnormalities, Chromosome|Chromosome Alterations|Chromosomal Abnormalities|chromosome aberrations|Aberration, Chromosome|Chromosome Abnormality|Chromosomal Alterations|Chromosome Abnormalities|chromosomal abnormalities|abnormal chromosomes|Chromosomal abnormalities|Aberrations, Cytogenetic|Abnormalities, Cytogenetic|Aberrant Chromosome|Cytogenetic Aberrations|chromosomal anomalies|Aberration, Chromosomal|chromosome aberration|Aberration, Cytogenetic|abnormal chromosome|Cytogenetic Abnormalities|Cytogenetic Aberration|Chromosomal Aberrations|Abnormality, Chromosome|chromosome abnormality|Aberrations, Chromosome|Abnormality, Chromosomal|chromosomal aberrations|Chromosome Aberrations|Chromosomal Aberration|chromosome abnormalities|Chromosome Anomalies|Chromosome abnormalities|chromosomal aberration|Chromosomal Abnormality|Aberrations, Chromosomal|Cytogenetic Abnormality|chromosomal abnormality|Abnormalities, Chromosomal | Chromosome Aberrations |
C0178638 | A cofactor for 1-carbon transfer involved with DNA synthesis. | folate|folates|Vitamin B-11|Folate | folate |
C1332977 | An acute or chronic leukemia that occurs during childhood. | Leukemia, Childhood|Leukemia in children|Leukemia|Childhood Leukemia | Childhood Leukemia |
C0040715 | Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome. | Chromosomal translocation, NOS|Genetic Translocation|CHROMOSOMAL TRANSLOCATIONS|Chromosomal Translocations|Translocations, Genetic|chromosomes translocation|Translocation (Genetics)|Chromosome Translocation|translocation|Translocations|t|Chromosomal translocation (morphologic abnormality)|chromosome translocation|Translocation, Chromosomal|genetic translocation|Chromosomal Translocation Process|chromosomal translocations|Translocations, Chromosomal|chromosome translocations|Translocation, Genetic|Chromosomal translocation|chromosomal translocation|Translocation|Genetic Translocations|genetic translocations|Chromosomal Translocation | Chromosomal translocation |
C1098510 | A drug used to prevent blood clots from forming inside blood vessels in the leg. It is being studied in the prevention of blood clots in some cancer patients, including women having surgery for cancer of the reproductive tract. It is a type of anticoagulant. | Natural heparin pentasaccharide|Fondaparinux|(2S,3S,4R,5R,6R)-6-((2R,3R,4R,5R,6R)-6-((2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl)oxy-5-sulfooxyoxan-3-yl)oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl)oxy-3-((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl)oxy-4,5-dihydroxyoxane-2-carboxylic acid|fondaparinux|Fondaparinux (substance)|Product containing fondaparinux (medicinal product)|Fondaparinux-containing product|FONDAPARINUX | fondaparinux |
C0003281 | Drug treatment to thin the blood in order to prevent or reduce blood clot formation. | Anticoagulation Therapy|anticoagulation therapy|anticoagulation|anticoagulation treatment|Anticoagulation Treatment | Anticoagulation Therapy |
C0007963 | null | chart|chart [medical device] | Charts (device) |
C0031048 | Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS. | Constrictive pericarditis|constrictive pericarditis|Pericarditides, Constrictive|Constrictive Pericarditis|CONSTRICTIVE PERICARDITIS|Constrictive Pericarditides|PERICARDITIS, CONSTRICTIVE|pericarditis constrictive|Constrictive pericarditis (disorder)|Pericarditis, Constrictive | Pericarditis, Constrictive |
C0007193 | Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure. | cardiomyopathy dilated|cardiomyopathy congestive|Congestive Cardiomyopathy|Cardiomyopathy, Dilated|Congestive cardiomyopathy (disorder)|Congestive dilated cardiomyopathy|CCM - Congestive cardiomyopathy|DCM - Dilated cardiomyopathy|Stretched and thinned heart muscle|dilated cardiomyopathy|primary dilated cardiomyopathy|Dilated Cardiomyopathies|congestive cardiomyopathy|COCM - Congestive cardiomyopathy|Congestive cardiomyopathy|Dilated cardiomyopathy|Cardiomyopathy, congestive|Primary dilated cardiomyopathy (disorder)|Cardiomyopathies, Dilated|Primary dilated cardiomyopathy|Dilated Cardiomyopathy|Cardiomyopathy, dilated | Cardiomyopathy, Dilated |
C0376387 | Individuals receiving tissues or organs transferred from another individual of the same or different species, or from within the same individual. | transplant recipient|Transplantation Recipient|Transplant Recipient|recipients transplant|Recipient, Transplant|transplant recipients|Transplant Recipients|Recipients, Transplant | Transplant Recipients |
C0033036 | A type of cardiac arrhythmia with premature atrial contractions or beats caused by signals originating from ectopic atrial sites. The ectopic signals may or may not conduct to the HEART VENTRICLES. Atrial premature complexes are characterized by premature P waves on ECG which are different in configuration from the P waves generated by the normal pacemaker complex in the SINOATRIAL NODE. | Atrial Premature Complex (APC)|apcs|Supraventricular Ectopic Beats|premature atrial systole|Atrial premature contractions|atrial premature complex|Supraventricular premature beats (disorder)|premature atrial contraction|Extrasystoles, Atrial|Atrial Ectopic Beat|Atrial Premature Complexes|atrial ectopics|Atrial Contraction, Premature|Premature Complex, Atrial|Supraventricular premature beats|Atrial premature depolarisation|Atrial Beat, Premature|Ectopic Beat, Atrial|premature atrial complexes|Premature Atrial Complex|Atrial Complex, Premature|Premature Atrial Contractions|atrial premature contractions|Atrial ectopic beats|Ectopic atrial beats|ATRIAL BEAT PREMATURE|Premature atrial contraction (disorder)|atrial ectopic|Premature Supraventricular Beats|Ectopic Beats, Atrial|atrial premature beat|Atrial Ectopic Beats|Premature atrial contractions|Supraventricular premature contraction|PACs|Atrial Premature Complex|Supraventricular extrasystoles|Atrial Beats, Premature|Atrial premature complex|Ectopic atrial beats, NOS|premature atrial complex|PAC|PAC - Premature atrial contraction|apc|Premature Atrial Contraction|Atrial Complices, Premature|Supraventricular Beats, Premature|Premature Complexes, Atrial|APC|Atrial extrasystoles|EXTRASYSTOLES ATRIAL|premature atrial beats|Atrial premature systoles|Premature atrial contraction (PAC)|supraventricular extrasystole|PREMATURE ATRIAL BEATS|Premature atrial contraction|Premature Supraventricular Beat|Premature atrial beats|supraventricular premature beats|Premature supraventricular beats|Atrial premature complex (disorder)|Atrial Contractions, Premature|Premature Atrial Beats|PREMATURE ATRIAL CONTRACTION|atrial premature complexes|premature atrial contractions|atrial ectopic beats|Ectopic supraventricular rhythms|Premature Atrial Complices|premature atrial beat|Atrial ectopic|Premature Complices, Atrial|Premature Atrial Beat|Atrial Premature Complices|ectopic atrial beats|Atrial premature depolarization|Extrasystole, Atrial|atrial premature beats|Atrial Extrasystoles|atrial ectopic beat|Atrial premature beats|premature atrial systoles|Atrial Extrasystole|Supraventricular Beat, Premature|EXTRASYSTOLES SUPRAVENTRICULAR|Ectopic atrial beats (disorder)|SUPRAVENTRICULAR EXTRASYSTOLES | Atrial Premature Complexes |
C0520887 | An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. | depressed st|ST Segment Depression by EKG Finding|ST segment depression (finding)|depressions st|ST SEGMENT DEPRESSED|S-T segment depressed|ST DEPRESSED|depressed segments st|ST depression|ST segment depression|depression st|ST DEPRESSION|st depression|Depression, ST Segment|ST Segment Depression by ECG Finding|depressed st segment|ST Depression|st segment depression|ST Segment Depression|depression segment st|ST Depression (observable entity) | ST segment depression (finding) |
C0010067 | The circulation of blood through the CORONARY VESSELS of the HEART. | Coronary Circulation|Circulation, Coronary|heart circulation|circulation coronary|coronary circulation|circulation heart|Coronary circulation | Coronary Circulation |
C0312422 | null | black out|blackout spell|BLACKOUT SPELL|blackout|blackouts|pass out|Blackout|BLACKOUT|black outs|passed out|blacking out|BLACK-OUT (NOT AMNESIA)|BLACK OUT | Blackout - symptom |
C0025465 | Arteries which arise from the abdominal aorta and distribute to most of the intestines. | Structure of mesenteric artery|mesenteric arteries|mesenteric artery|ARTERY, MESENTERIC|Mesenteric artery, NOS|Mesenteric artery|Arteries, Mesenteric|Mesenteric Artery|Structure of mesenteric artery (body structure)|MESENTERIC ARTERY|Mesenteric Arteries|MESENTERIC ARTERIES|Artery, Mesenteric|artery mesenteric | Mesenteric Arteries |
C0017628 | An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide. | Glibenclamide|GLYBURIDE|Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-|glibenclamide|Glyburide|Glybenclamide|Glibenclamida|5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|glyBURIDE|glybenclamide|Glyburide-containing product|glyburide|Glibenclamide-containing product|Product containing glibenclamide (medicinal product)|1-((p-(2-(5-chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamidum|Glibenclamide (substance)|Glybenzcyclamide|1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea | glyburide |
C1537011 | A class of eicosanoids produced by the epoxidation of one of the double bonds of arachidonic acid by some of the members of the cytochrome P450 family of epoxygenases. Epoxides in the epoxyeicosatrienoic acid (EET) family act locally to stimulate signaling pathways involved in the regulation of blood pressure, vascular maintenance, inflammation, and pain responses. EETs may promote the proliferation and survival of certain types of cancer cells. | EETs|Epoxyicosatrienoic Acids|EET|Epoxyicosatrienoic Acid|Epoxyeicosatrienoic Acid | Epoxyeicosatrienoic Acid |
C0746731 | null | Acute myocardial ischemia (disorder)|Acute myocardial ischaemia | Acute myocardial ischemia |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.